NSEAnalysts/Institutional Investor Meet/Con. Call Updates26 Oct 2026 · 26 Oct 2026, 07:40 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Mankind Pharma Limited · MANKIND
✦ AI SummaryResults
Mankind Pharma Limited has made available the audio recording of its earnings conference call for Q2 & H1 FY27, as per Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Limited has informed the Exchange about Link of Recording
Attachments (1)
📄pdf
Download →
MANKIND1_26102026194044_AudioRecordingsd.pdf
View document text
October 26, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543904 Symbol: MANKIND
Dear Sir/ Madam,
Subject: Earnings Conference Call for Q2 & H1 FY27 – Audio Recording
Pursuant to Regulation 30 & 51 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, and further to our intimations
dated October 12, 2026, titled “Intimation of Earnings Conference Call for Q2 & H1 FY27”
and October 22, 2026, titled “Rescheduling of Earnings Conference Call for Q2 & H1 FY27”,
we wish to inform you that the audio recording of the Earnings Conference Call held today,
i.e., October 26, 2026, is available at the following link: Link to access Audio Recording
You are requested to kindly take the same on records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer